105 related articles for article (PubMed ID: 16954034)
1. Noninvasive optical imaging of ovarian metastases using Cy5-labeled RAFT-c(-RGDfK-)4.
Jin ZH; Josserand V; Razkin J; Garanger E; Boturyn D; Favrot MC; Dumy P; Coll JL
Mol Imaging; 2006 Jul; 5(3):188-97. PubMed ID: 16954034
[TBL] [Abstract][Full Text] [Related]
2. In vivo noninvasive optical imaging of receptor-mediated RGD internalization using self-quenched Cy5-labeled RAFT-c(-RGDfK-)(4).
Jin ZH; Razkin J; Josserand V; Boturyn D; Grichine A; Texier I; Favrot MC; Dumy P; Coll JL
Mol Imaging; 2007; 6(1):43-55. PubMed ID: 17311764
[TBL] [Abstract][Full Text] [Related]
3. In vivo optical imaging of integrin alphaV-beta3 in mice using multivalent or monovalent cRGD targeting vectors.
Jin ZH; Josserand V; Foillard S; Boturyn D; Dumy P; Favrot MC; Coll JL
Mol Cancer; 2007 Jun; 6():41. PubMed ID: 17565663
[TBL] [Abstract][Full Text] [Related]
4. Noninvasive visualization and quantification of tumor αVβ3 integrin expression using a novel positron emission tomography probe, 64Cu-cyclam-RAFT-c(-RGDfK-)4.
Jin ZH; Furukawa T; Galibert M; Boturyn D; Coll JL; Fukumura T; Saga T; Dumy P; Fujibayashi Y
Nucl Med Biol; 2011 May; 38(4):529-40. PubMed ID: 21531290
[TBL] [Abstract][Full Text] [Related]
5. αVβ3 Integrin-Targeted Radionuclide Therapy with 64Cu-cyclam-RAFT-c(-RGDfK-)4.
Jin ZH; Furukawa T; Degardin M; Sugyo A; Tsuji AB; Yamasaki T; Kawamura K; Fujibayashi Y; Zhang MR; Boturyn D; Dumy P; Saga T
Mol Cancer Ther; 2016 Sep; 15(9):2076-85. PubMed ID: 27422811
[TBL] [Abstract][Full Text] [Related]
6. Tumor targeting with radiolabeled alpha(v)beta(3) integrin binding peptides in a nude mouse model.
Janssen ML; Oyen WJ; Dijkgraaf I; Massuger LF; Frielink C; Edwards DS; Rajopadhye M; Boonstra H; Corstens FH; Boerman OC
Cancer Res; 2002 Nov; 62(21):6146-51. PubMed ID: 12414640
[TBL] [Abstract][Full Text] [Related]
7. 67Cu-Radiolabeling of a multimeric RGD peptide for αVβ3 integrin-targeted radionuclide therapy: stability, therapeutic efficacy, and safety studies in mice.
Jin ZH; Furukawa T; Ohya T; Degardin M; Sugyo A; Tsuji AB; Fujibayashi Y; Zhang MR; Higashi T; Boturyn D; Dumy P; Saga T
Nucl Med Commun; 2017 Apr; 38(4):347-355. PubMed ID: 28291159
[TBL] [Abstract][Full Text] [Related]
8. alpha(v)beta(3) Integrin-targeting radionuclide therapy and imaging with monomeric RGD peptide.
Yoshimoto M; Ogawa K; Washiyama K; Shikano N; Mori H; Amano R; Kawai K
Int J Cancer; 2008 Aug; 123(3):709-15. PubMed ID: 18498129
[TBL] [Abstract][Full Text] [Related]
9. New multifunctional molecular conjugate vector for targeting, imaging, and therapy of tumors.
Garanger E; Boturyn D; Jin Z; Dumy P; Favrot MC; Coll JL
Mol Ther; 2005 Dec; 12(6):1168-75. PubMed ID: 16051524
[TBL] [Abstract][Full Text] [Related]
10. Micro-positron emission tomography/contrast-enhanced computed tomography imaging of orthotopic pancreatic tumor-bearing mice using the αvβ₃ integrin tracer ⁶⁴Cu-labeled cyclam-RAFT-c(-RGDfK-)₄.
Aung W; Jin ZH; Furukawa T; Claron M; Boturyn D; Sogawa C; Tsuji AB; Wakizaka H; Fukumura T; Fujibayashi Y; Dumy P; Saga T
Mol Imaging; 2013 Sep; 12(6):376-87. PubMed ID: 23981783
[TBL] [Abstract][Full Text] [Related]
11. Targeted radionuclide therapy with RAFT-RGD radiolabelled with (90)Y or (177)Lu in a mouse model of αvβ3-expressing tumours.
Bozon-Petitprin A; Bacot S; Gauchez AS; Ahmadi M; Bourre JC; Marti-Batlle D; Perret P; Broisat A; Riou LM; Claron M; Boturyn D; Fagret D; Ghezzi C; Vuillez JP
Eur J Nucl Med Mol Imaging; 2015 Feb; 42(2):252-63. PubMed ID: 25164771
[TBL] [Abstract][Full Text] [Related]
12. Reduction of renal uptake of 111In-DOTA-labeled and A700-labeled RAFT-RGD during integrin αvβ3 targeting using single photon emission computed tomography and optical imaging.
Briat A; Wenk CH; Ahmadi M; Claron M; Boturyn D; Josserand V; Dumy P; Fagret D; Coll JL; Ghezzi C; Sancey L; Vuillez JP
Cancer Sci; 2012 Jun; 103(6):1105-10. PubMed ID: 22448775
[TBL] [Abstract][Full Text] [Related]
13. PET imaging and biodistribution analysis of the effects of succinylated gelatin combined with L-lysine on renal uptake and retention of ⁶⁴Cu-cyclam-RAFT-c(-RGDfK-)₄ in vivo.
Jin ZH; Furukawa T; Sogawa C; Claron M; Aung W; Tsuji AB; Wakizaka H; Zhang MR; Boturyn D; Dumy P; Fujibayashi Y; Saga T
Eur J Pharm Biopharm; 2014 Apr; 86(3):478-86. PubMed ID: 24316338
[TBL] [Abstract][Full Text] [Related]
14. Clustering and internalization of integrin alphavbeta3 with a tetrameric RGD-synthetic peptide.
Sancey L; Lucie S; Garanger E; Elisabeth G; Foillard S; Stéphanie F; Schoehn G; Guy S; Hurbin A; Amandine H; Albiges-Rizo C; Corinne AR; Boturyn D; Didier B; Souchier C; Catherine S; Grichine A; Alexeï G; Dumy P; Pascal D; Coll JL; Jean-Luc C
Mol Ther; 2009 May; 17(5):837-43. PubMed ID: 19259068
[TBL] [Abstract][Full Text] [Related]
15. Alpha v beta 3 integrin-targeting of intraperitoneally growing tumors with a radiolabeled RGD peptide.
Dijkgraaf I; Kruijtzer JA; Frielink C; Corstens FH; Oyen WJ; Liskamp RM; Boerman OC
Int J Cancer; 2007 Feb; 120(3):605-10. PubMed ID: 17096340
[TBL] [Abstract][Full Text] [Related]
16. Radiotheranostic Agent
Jin ZH; Tsuji AB; Degardin M; Sugyo A; Obara S; Wakizaka H; Nagatsu K; Hu K; Zhang MR; Dumy P; Boturyn D; Higashi T
Clin Cancer Res; 2020 Dec; 26(23):6230-6241. PubMed ID: 32933998
[TBL] [Abstract][Full Text] [Related]
17. Optical imaging of integrin alphavbeta3 expression with near-infrared fluorescent RGD dimer with tetra(ethylene glycol) linkers.
Liu Z; Liu S; Niu G; Wang F; Liu S; Chen X
Mol Imaging; 2010 Feb; 9(1):21-9. PubMed ID: 20128995
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
